Carcinoma of the prostate: the treatment of bone metastases by radioactive phosphorus (TSP)

Journal Article · Tue Jan 01 00:00:00 EST 1985 · Int. Surg.; (United States)

OSTI ID:6082675

Ariel, I M; Hassouna, H

The administration of radioactive phosphorus and testosterone benefitted two-thirds of thirty patients with prostate cancer treated. Subjective relief of bone pain occurred in 73% of cases and measurable objective improvement occurred in 50%. Hematopoietic depression occurred in 30% of the patients necessitating readmission to hospital for transfusion. This method of treatment is advocated for patients with widespread osseous metastasis, especially those with severe pain.

• Research Organization: Pack Medical Foundation, New York, NY
• OSTI ID: 6082675
• Journal Information: Int. Surg.; (United States), Vol. 1
• Country of Publication: United States
• Language: English

Related Subjects

62 RADIOLOGY AND NUCLEAR MEDICINE
63 RADIATION, THERMAL, AND OTHER ENVIRON. POLLUTANT EFFECTS ON LIVING ORGS. AND BIOL. MAT.
IMMUNOSUPPRESSION
RADIOINDUCTION
METASTASES
RADIOTHERAPY
ACID PHOSPHATASE
CARCINOMAS
PAIN
PATIENTS
PHOSPHORUS 32
PROSTATE
SKELETON
TESTOSTERONE
ANDROGENS
ANDROSTANES
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
DAYS LIVING RADIOISOTOPES
DISEASES
ENZYMES
ESTERASES
GLANDS
HORMONES
HYDROLASES
HYDROXY COMPOUNDS
ISOTOPES
KETONES
LIGHT NUCLEI
MALE GENITALS
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
ORGANS
PHOSPHATASES
PHOSPHORUS ISOTOPES
RADIOISOTOPES
RADIOLOGY
STEROID HORMONES
STEROIDS
SYMPTOMS
THERAPY
550604* - Medicine- Unsealed Radionuclides in Therapy- (1980-)
560151 - Radiation Effects on Animals- Man